Use of proepithelin to promote wound repair and reduce inflammation
US7427595B1 · kind B1 · utility
12Cited by
1References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 12, 2003 |
| Grant date | Sep 23, 2008 |
| Priority date | — |
| Expiry date | Aug 24, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/47
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to compositions and methods for wound healing and controlling inflammation that involve proepithelin, with or without secretory leukocyte protease inhibitor (SLPI).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.